|1.||Gupta, Somesh: 2 articles (11/2014 - 10/2014)|
|2.||Katoch, K: 2 articles (10/2012 - 02/2008)|
|3.||Singh, Padam: 2 articles (02/2008 - 06/2005)|
|4.||Benara, S K: 2 articles (02/2008 - 06/2005)|
|5.||Kumar, B: 2 articles (02/2005 - 09/2001)|
|6.||Kaur, I: 2 articles (02/2005 - 09/2001)|
|7.||Rani, R: 2 articles (06/2000 - 06/2000)|
|8.||Mukherjee, R: 2 articles (06/2000 - 06/2000)|
|9.||Misra, R S: 2 articles (06/2000 - 06/2000)|
|10.||Mukherjee, A: 2 articles (06/2000 - 06/2000)|
|1.||Leprosy (Hansen's Disease)
09/01/2001 - "The addition of Mycobacterium w vaccine as an adjunct to the 1-year WHO/MDT regimen appears to be significantly more beneficial in MB leprosy patients with a high initial BI compared to WHO/MDT given alone. "
10/01/2012 - "A total of 150 cases in one treatment (trial) group (Mw vaccine plus MDT) and 120 cases in another treatment (control) group (MDT only) of border line leprosy have been included. "
06/01/2005 - "Immunoprophylactic effects of the anti-leprosy Mw vaccine in household contacts of leprosy patients: clinical field trials with a follow up of 8-10 years."
06/01/2000 - "To conclude, although a study of small sample size, the preliminary evaluation indicates that administration of Mycobacterium w vaccine seems to have the potential to reduce the incidence of leprosy among household contacts of leprosy patients. "
12/01/1993 - "Field trials on the use of Mycobacterium w vaccine in conjunction with multidrug therapy in leprosy patients for immunotherapeutic and immunoprophylactic purposes."
11/01/2014 - "Killed Mw vaccine is safe and effective in the treatment of extensive cutaneous warts. "
11/01/2014 - "In this study, a retrospective analysis of medical records was performed in patients with cutaneous warts treated with intralesional Mw vaccine. "
10/01/2014 - "We conducted a study to assess the efficacy and safety of intralesional Mycobacterium w vaccine for the treatment of warts at sites that were difficult to treat. "
11/01/2014 - "To evaluate the efficacy and safety profile of intralesional injected killed Mw vaccine for the treatment of extensive extragenital cutaneous warts. "
10/01/2014 - "Thirty patients with at least one wart present on either the plantar surface of their feet, palms, volar aspect of their fingers, or periungual or subungual region, were treated with 0.1 ml of killed Mycobacterium w vaccine given intralesionally in a single wart, without any prior sensitisation dose. "
06/01/2005 - "In our study, BCG exhibited slightly better and faster effect on bacteriological clearance and clinical improvement as compared to Mw vaccine in borderline lepromatous (BL)/ polar lepromatous (LL) patients with a high initial B.I., however, their effect on histopathological (decrease in GF) improvement was comparable. "
09/01/2001 - "Impact of combined Mycobacterium w vaccine and 1 year of MDT on multibacillary leprosy patients."
06/01/2000 - "Mycobacterium w vaccine, a useful adjuvant to multidrug therapy in multibacillary leprosy: a report on hospital based immunotherapeutic clinical trials with a follow-up of 1-7 years after treatment."
08/01/1995 - "Addition of immunotherapy with Mycobacterium w vaccine to multi-drug therapy benefits multibacillary leprosy patients."
01/01/1992 - "Association of HLA antigens with differential responsiveness to Mycobacterium w vaccine in multibacillary leprosy patients."
|4.||Condylomata Acuminata (Genital Wart)
11/01/2014 - "Killed Mycobacterium indicus pranii (previously known as Mycobacterium w, popularly known as Mw) vaccine has earlier been investigated in genital warts with encouraging results. "
09/01/2008 - "To evaluate the efficacy and safety of intralesional Mycobacterium w (Mw) vaccine monotherapy for the treatment of ano-genital warts. "
09/01/2008 - "Intralesional immunotherapy of ano-genital warts with Mw vaccine seems to be a promising new approach, which needs to be evaluated in the randomized controlled trials."
09/01/2008 - "Mw vaccine (0.1 mL) was initially injected intradermally in the deltoid region on both the sides, followed 2 weeks later by intradermal intralesional injection into the genital warts. "
09/01/2008 - "Intralesional immunotherapy with killed Mycobacterium w vaccine for the treatment of ano-genital warts: an open label pilot study."
02/26/2008 - "In the placebo group the prevalence of tuberculosis was 1.11% which reduced to 0.70% for those who received Mw vaccine (p<0.01) which further decreased to 0.53% in those who had BCG scars and received Mw. "
04/01/2013 - "It is therefore inferred that, contrary to its role in managing tuberculosis and leprosy infections, Mw vaccine has not been successful in controlling VL infection, emphasizing the need to find detailed explanations for the failure of this vaccine against the disease."
|3.||HLA Antigens (Human Leukocyte Antigens)
|2.||Drug Therapy (Chemotherapy)